U.S. Basic Materials Stock News

NasdaqGM:STAA
NasdaqGM:STAAMedical Equipment

STAAR Surgical (STAA) Posts US$80.4 Million Annual Loss Testing Turnaround Narratives

STAAR Surgical FY 2025 earnings snapshot STAAR Surgical (STAA) has wrapped up FY 2025 with Q4 revenue of US$57.8 million and a basic EPS loss of US$0.37, keeping the focus firmly on the path back to profitability. The company has seen quarterly revenue range from US$42.6 million to US$94.7 million since the start of 2024, while basic EPS has swung between a loss of US$1.10 and a profit of US$0.20. This sets up a mixed picture on margins that investors may view as an ongoing turnaround story...
NYSE:XPEV
NYSE:XPEVAuto

XPeng (XPEV) Valuation Check As Delivery Headwinds Meet New Models And Volkswagen AD Partnership

XPeng (XPEV) just reported February 2026 deliveries of 15,256 vehicles, alongside plans to roll out new models and supply its second generation assisted driving solution to Volkswagen, giving investors fresh data points to reassess the stock. See our latest analysis for XPeng. At a share price of US$16.17, XPeng has seen a 1 day share price return of 1.89%. However, the 7 day and year to date share price returns of 11.06% and 20.85% declines suggest momentum has cooled. This comes even as the...
NasdaqGS:CRCT
NasdaqGS:CRCTConsumer Durables

Cricut (CRCT) Margin Improvement Challenges Bearish Earnings Narratives After FY 2025 Results

Cricut (CRCT) just wrapped up FY 2025 with fourth quarter revenue of US$203.6 million and basic EPS of US$0.04, alongside net income of US$7.8 million, setting the tone for how the full year is being read by the market. The company has seen quarterly revenue shift from US$209.3 million with EPS of US$0.06 in Q4 2024 to US$203.6 million with EPS of US$0.04 in Q4 2025. Trailing twelve month EPS sits at US$0.36 on revenue of US$708.8 million, and that mix of steady top line and improving...
NasdaqGS:JAZZ
NasdaqGS:JAZZPharmaceuticals

Assessing Jazz Pharmaceuticals (JAZZ) Valuation After Mixed Recent Returns And A 5.7% Undervaluation Estimate

Recent performance snapshot for Jazz Pharmaceuticals (JAZZ) Jazz Pharmaceuticals (JAZZ) has attracted attention after a period of mixed short term moves and stronger longer term returns, with the stock closing at $188.69 and showing positive figures across several multi year horizons. See our latest analysis for Jazz Pharmaceuticals. Recent moves have been choppy, with a 1 day share price return of 1.08% and a 7 day share price return showing a 4.14% decline. However, the 30 day share price...
NasdaqCM:SRTA
NasdaqCM:SRTAHealthcare

Strata Critical Medical Q4 Loss Underscores Ongoing Profitability Gap Versus Bullish Narratives

Strata Critical Medical (SRTA) has reported its FY 2025 numbers, with Q4 revenue at US$66.8 million and a basic EPS loss of US$0.06. Trailing twelve month revenue came in at US$197.1 million with a full year basic EPS loss of US$0.24. Over recent quarters, the company has reported revenue in a range from US$36.1 million to US$66.8 million, while quarterly basic EPS losses have moved between US$0.04 and US$0.12. This keeps the focus on how efficiently it is converting sales into earnings. With...
NasdaqGS:AVGO
NasdaqGS:AVGOSemiconductor

Broadcom Deepens AI Telco Push As Valuation Sits Near Fair Value

Broadcom (NasdaqGS:AVGO) launched VMware Telco Cloud Platform 9, bringing AI-native, private and sovereign telco cloud capabilities to operators. The company introduced an advanced 2nm custom compute SoC using 3.5D XDSiP packaging aimed at high-performance AI workloads. Broadcom and Altera announced an interoperability partnership between Broadcom's BroadPeak SoC and Altera Agilex 7 to support AI-powered 5G and future wireless networks. For you as an investor, these moves sit at the...
NasdaqGS:TSLA
NasdaqGS:TSLAAuto

Bank of America’s Robotaxi Focus Could Be A Game Changer For Tesla’s (TSLA) Investment Narrative

In recent days, Bank of America reinstated coverage of Tesla, highlighting its leadership in consumer-focused autonomy, robotaxis operating in cities like Austin and San Francisco, and longer-term opportunities in Optimus humanoid robots and energy storage. This renewed analyst focus underscores how Tesla’s push to become a “physical AI” and software-led mobility platform is increasingly central to how investors view the business, beyond its core electric vehicle sales. We’ll now examine...
NYSE:CTRE
NYSE:CTREHealth Care REITs

Assessing CareTrust REIT’s (CTRE) Valuation After Earnings Beat And Expansion Into UK Care Properties

CareTrust REIT (CTRE) is back in focus after reporting earnings and revenue that exceeded analyst estimates, while also expanding its healthcare property footprint through acquisitions in the United States and the United Kingdom. See our latest analysis for CareTrust REIT. At a recent share price of US$39.29, CareTrust REIT has seen a 7.9% 1 month share price return and an 8.2% year to date share price return. Its 1 year total shareholder return of 54.3% and 3 year total shareholder return...
NYSE:TPL
NYSE:TPLOil and Gas

Texas Pacific Land (TPL) Valuation After Record Results And New Power And Data Center Prospects

Texas Pacific Land (TPL) is back in focus after record Q4 and full year results, with rising oil and gas royalty volumes, strong water sales, insider buying, and fresh interest around power and data center projects. See our latest analysis for Texas Pacific Land. That backdrop of record results, data center and power opportunities, and steady insider buying has coincided with sharp momentum, with a 59.23% 1 month share price return and a 277.03% 5 year total shareholder return suggesting...
NasdaqCM:UFPT
NasdaqCM:UFPTMedical Equipment

Does UFP Technologies' (UFPT) Expanded Intuitive Deal Reframe Its Medical Automation Investment Narrative?

In late February 2026, UFP Technologies, Inc. extended and expanded its manufacturing supply agreement with Intuitive Surgical through December 31, 2029, while also reporting higher fourth-quarter and full-year 2025 sales and earnings compared with the prior year. This combination of a longer-term, higher-volume partnership with a key customer and recent earnings growth adds further visibility to UFP Technologies’ medical device exposure and contracted revenue base. Next, we’ll examine how...
NasdaqGS:HBAN
NasdaqGS:HBANBanks

Should Renewed Analyst Focus On Regional Bank Profit Resilience Require Action From Huntington Bancshares (HBAN) Investors?

In recent days, Huntington Bancshares has been in focus as analysts reassessed U.S. regional banks, highlighting expectations for resilient profits ahead of upcoming earnings. This wave of analyst attention, combined with a more constructive view on regional bank fundamentals, has reinforced Huntington’s positioning within the sector. Now we’ll explore how this renewed analyst confidence in regional banks, especially around profit resilience, could influence Huntington’s investment...
NasdaqGS:PRAX
NasdaqGS:PRAXBiotechs

A Look At Praxis Precision Medicines (PRAX) Valuation After Wider Full Year And Q4 Net Loss

Praxis Precision Medicines (PRAX) recently reported fourth quarter and full year 2025 results, with net loss and loss per share from continuing operations higher than the prior year. This has put the company’s cash burn and pipeline priorities in sharper focus for investors. See our latest analysis for Praxis Precision Medicines. The stock has been volatile, with a 1 day share price return of 2.17% and a 90 day share price return of 71.14%. The 1 year total shareholder return is very large,...
NasdaqGS:EYE
NasdaqGS:EYESpecialty Retail

Same Store Sales Strength Tests Profitability Concerns At National Vision Holdings (EYE)

National Vision Holdings (EYE) has put up a mixed FY 2025 scorecard so far, with Q3 revenue at US$487.3 million, basic EPS of US$0.04 and same store sales growth of 7.7%, set against a trailing twelve month loss of US$3.2 million and basic EPS of roughly US$0.04 loss. Over recent quarters the company has seen revenue range from US$451.7 million in Q2 2024 to US$510.3 million in Q1 2025. Basic EPS has moved from a Q4 2024 loss of US$0.37 per share to a Q1 2025 profit of US$0.18 per share and...
NYSE:AVNT
NYSE:AVNTChemicals

Assessing Avient (AVNT) Valuation As Recent Share Moves Contrast With Mixed Longer Term Returns

Avient stock in focus Avient (AVNT) is drawing fresh attention after recent share price moves, with the stock closing at $39.90. For investors, the latest returns across the month and past 3 months invite a closer look. See our latest analysis for Avient. Avient’s recent share price pullback over the past week sits against a stronger backdrop, with a 30 day share price return of 9.17% and a 90 day share price return of 28.96%. However, the 1 year total shareholder return of a 2.10% decline...
NYSE:ACEL
NYSE:ACELHospitality

Accel Entertainment (ACEL) Margin Improvement Challenges Bears Focused On Concentration Risks

Accel Entertainment (ACEL) has wrapped up FY 2025 with fourth quarter revenue of US$341.4 million and EPS of US$0.19, capping a year in which trailing twelve month revenue reached US$1.3 billion and EPS came in at US$0.61. The company has seen quarterly revenue move from US$302.2 million in Q3 2024 to US$341.4 million in Q4 2025, while quarterly EPS stepped up from US$0.06 to US$0.19 over the same stretch, setting the backdrop for investors focused on earnings growth and profit consistency...
NYSE:BF.B
NYSE:BF.BBeverage

Brown Forman (BF.B) Margin Compression Challenges Bullish Premiumization Narrative

Brown Forman (BF.B) has just put out its Q3 2026 scorecard, with Q2 fiscal 2026 revenue of US$1.0 billion and basic EPS of US$0.47, supported by net income of US$224 million. Over recent quarters the company has seen revenue move from US$1.1 billion and EPS of US$0.55 in Q2 fiscal 2025 to US$1.0 billion and EPS of US$0.47 in Q2 fiscal 2026. Trailing 12 month EPS of about US$1.71 on revenue of US$3.9 billion gives investors a clearer read on the earnings run rate. Set against these headline...
NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

GLOBALFOUNDRIES (GFS) Valuation Check After Strong Q4 2025 Beat And Renesas Partnership

GLOBALFOUNDRIES (GFS) has been in focus after its Q4 2025 earnings came in above the top end of management guidance, alongside a new multi billion dollar manufacturing partnership with Renesas Electronics. See our latest analysis for GLOBALFOUNDRIES. The strong Q4 report and Renesas partnership appear to have supported GLOBALFOUNDRIES’ recent momentum, with a 12.78% 1 month share price return contributing to a 26.58% 3 month gain and a 24.40% 1 year total shareholder return, even though the 3...
NasdaqGS:NBTB
NasdaqGS:NBTBBanks

A Look At NBT Bancorp (NBTB) Valuation After Recent Share Price Weakness

Why NBT Bancorp Is On Investor Radars Today NBT Bancorp (NBTB) has attracted fresh attention after a recent share price move, with the stock closing at $43.01. That reaction has investors reassessing the bank's valuation and return profile. See our latest analysis for NBT Bancorp. The latest uptick comes after a choppy spell, with a 7 day share price return of a 4.87% decline and a 30 day share price return of a 5.29% decline. The year to date share price return of 3.41% and the 3 year total...
NasdaqCM:ALMU
NasdaqCM:ALMUSemiconductor

Is Benchmark’s Renewed Aeluma (ALMU) Rating Quietly Reframing Its AI-Optics Competitive Narrative?

On 3 March 2026, Benchmark reaffirmed its positive analyst rating on Aeluma, Inc., citing Nvidia’s recent optical investments as an important sector reference point for the company’s technology focus. This endorsement underscores how investor attention around Aeluma is increasingly tied to perceived alignment with larger industry players pursuing advanced optical solutions for AI infrastructure. We’ll now examine how Benchmark’s renewed confidence, anchored in Nvidia’s optical investment...
NasdaqGS:AMZN
NasdaqGS:AMZNMultiline Retail

A Look At Amazon.com (AMZN) Valuation After Drone Strikes Hit Key Middle East AWS Data Centers

Amazon.com (AMZN) is under close watch after drone strikes damaged three Amazon Web Services data centers in the UAE and Bahrain, triggering service outages and fresh questions about cloud reliability in conflict zones. See our latest analysis for Amazon.com. Investors had already been wrestling with Amazon.com’s heavy AI and data center spending, which contributed to a 10.76% decline in its 30 day share price return and a 4.27% share price return decline year to date. Recent partnerships...
NasdaqGS:SWIM
NasdaqGS:SWIMLeisure

Latham Group (SWIM) Turns TTM Profitable Challenging Cautious Earnings Narratives

Latham Group (SWIM) closed out FY 2025 with Q4 revenue of US$99.9 million and a basic EPS loss of US$0.06, while trailing 12 month figures showed revenue of US$545.9 million and basic EPS of US$0.10. Over recent quarters, the company has seen revenue move from US$150.5 million in Q3 2024 to US$172.6 million in Q2 2025 before settling at US$99.9 million in Q4 2025, with basic EPS ranging from a loss of US$0.25 in Q4 2024 to a profit of US$0.14 in Q2 2025. For investors, the current release...
NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

CrowdStrike (CRWD) First Profitable Quarter Challenges Trailing Loss Narrative

CrowdStrike Holdings (CRWD) FY 2026 results in focus CrowdStrike Holdings (CRWD) has capped FY 2026 with fourth quarter revenue of about US$1.3 billion and basic EPS of US$0.15, alongside trailing twelve month revenue of roughly US$4.8 billion and a trailing basic EPS loss of US$0.65. The company has seen quarterly revenue move from US$1.06 billion in Q4 FY 2025 to US$1.31 billion in Q4 FY 2026, while basic EPS shifted from a loss of US$0.37 to a profit of US$0.15 over the same periods. For...
NYSE:FICO
NYSE:FICOSoftware

FICO Education Push With Banzai And NFCC Meets Premium Valuation

FICO (NYSE:FICO) has partnered with Banzai to bring credit and financial literacy education to more than 70% of U.S. K-12 schools. The collaboration gives millions of students and 150,000 teachers access to credit education tools as part of a broader financial literacy push. Separately, the National Foundation for Credit Counseling (NFCC) is expanding its work with FICO to widen access to debt relief resources that use FICO scores. For investors watching NYSE:FICO, these moves highlight how...
NYSE:BRK.A
NYSE:BRK.ADiversified Financial

Greg Abel Sets Course For Berkshire Hathaway As Valuation Debate Persists

Greg Abel has issued his first shareholder letter as CEO of Berkshire Hathaway, outlining his vision for the company’s stewardship and long term value creation. The transition formalizes Berkshire’s leadership shift while Warren Buffett remains involved as chairman. Abel highlighted continuity, adjustments to capital allocation, an upcoming CFO succession, and a stronger focus on operational cash flow metrics. NYSE:BRK.A currently trades at $730,707.0, with a 3 year return of 54.8% and a 5...